The U.S. Food and Drug Administration (FDA) and an advisory panel for the Centers for Disease Control and Prevention say Americans aged 65 years and older, and those who have a high risk for severe disease should receive a third dose of the Pfizer-BioNTech COVID-19 vaccine. Jackson Proskow reports on if Canada is looking to follow suit, and how scientists feel about the general public getting a third dose.
- U.S. FDA panel backs booster shot for Johnson & Johnson COVID-19 vaccine
- Experts concerned COVID-19 booster shots will hurt efforts to reach the unvaccinated
- Pfizer launches large study of oral COVID-19 prevention drug